Female Infertility Industry Data Book - In Vitro Fertilization (IVF) and Artificial Insemination Market Size, Share, Trends Analysis, And Segment Forecasts, 2023 - 2030
- Published Date: Jul, 2023
- Report ID: sector-report-00182
- Format: Electronic (PDF)
- Number of Pages: 350
Chapter 1 Methodology and Scope
- 1.1 Market Segmentation and Scope
- 1.2 Market Definition
- 1.3 Research Methodology
- 1.3.1 Information Procurement
- 1.3.1.1 Purchased database:
- 1.3.1.2 GVR’s internal database
- 1.3.2 Primary Research:
- 1.4 Research Scope and Assumptions
- 1.5 List of Data Sources
Chapter 2 Executive Summary
- 2.1 Market Outlook
- 2.2 Product Outlook
- 2.3 End-use Outlook
- 2.4 Regional Outlook
- 2.5 Competitive Outlook
- 2.6 Female Infertility Market Snapshot
Chapter 3 Female Infertility Market Variables, Trends & Scope
- 3.1 Penetration and Growth Prospect Mapping
- 3.2 Market Dynamics
- 3.2.1 Market Driver Analysis
- 3.2.2 Market Restraint Analysis
- 3.2.3 Market Challenges
- 3.3 Female Infertility Market Analysis Tools
- 3.3.1 Industry Analysis - Porter’s
- 3.3.1.1 Bargaining power of the suppliers -
- 3.3.1.2 Bargaining power of the buyers -
- 3.3.1.3 Threats of substitution -
- 3.3.1.4 Threats from new entrants -
- 3.3.1.5 Competitive rivalry -
- 3.3.2 PEST Analysis
- 3.3.2.1 Political Landscape
- 3.3.2.2 Economic Landscape
- 3.3.2.3 Social Landscape
- 3.3.2.4 Technology Landscape
- 3.4 Regulatory Landscape
- 3.5 Technology Landscape
- 3.5.1 Pipeline analysis (Upcoming technologies)
- 3.6 Impact of COVID-19 on the Female Infertility Market
Chapter 4 Female Infertility Market: Competitive Landscape Analysis
- 4.1 Recent Developments & Impact Analysis, by Key Market Participants
- 4.2 Company/Competition Categorization (Key innovators, Market leaders, Emerging players)
- 4.3 Vendor Landscape
- 4.3.1 A partial list of key distributors and channel partners
- 4.3.2 Key customers
- 4.3.3 Key company market share analysis, 2022
- 4.3.4 Public Companies
- 4.3.4.1 Company Market Position Analysis (Geographic Presence, Product Portfolio, Key Alliance, Industry Experience)
- 4.3.4.2 Company market share analysis
- 4.3.4.3 Market differentiators
- 4.3.5 Private companies
- 4.3.5.1 List of key emerging companies
- 4.3.5.2 Regional network map
- 4.3.5.3 Company market position analysis (Geographic Presence, Product Portfolio, Key Alliance, Industry Experience)
Chapter 5 Female Infertility Market Therapeutic Areas Analysis
- 5.1 Female Infertility Market: Therapeutic Areas Movement Analysis 2022 & 2030 (USD Million)
- 5.2 In Vitro Fertilization (IVF)
- 5.2.1 In Vitro Fertilization (IVF) market estimates and forecasts, by procedure type, 2018 - 2030 (USD Million)
- 5.2.2 Fresh Donor
- 5.2.2.1 Fresh Donor market estimates and forecasts, 2018 - 2030 (USD Million)
- 5.2.3 Frozen Donor
- 5.2.3.1 Frozen Donor market estimates and forecasts, 2018 - 2030 (USD Million)
- 5.2.4 Fresh Non-donor
- 5.2.4.1 Fresh Non-donor market estimates and forecasts, 2018 - 2030 (USD Million)
- 5.2.5 Frozen Non-donor
- 5.2.5.1 Frozen Non-donor market estimates and forecasts, 2018 - 2030 (USD Million)
- 5.3 Artificial Insemination
- 5.3.1 Artificial insemination market estimates and forecasts, by procedure type, 2018 - 2030 (USD Million)
- 5.3.2 Intrauterine Insemination
- 5.3.2.1 Intrauterine insemination market estimates and forecasts, 2018 - 2030 (USD Million)
- 5.3.3 Intracervical Insemination
- 5.3.3.1 Intracervical insemination market estimates and forecasts, 2018 - 2030 (USD Million)
- 5.3.4 Intravaginal Insemination
- 5.3.4.1 Intravaginal insemination market estimates and forecasts, 2018 - 2030 (USD Million)
- 5.3.5 Intratubal Insemination
- 5.3.5.1 Intratubal insemination market estimates and forecasts, 2018 - 2030 (USD Million)
Chapter 6 Female Infertility Market End-use Analysis
- 6.1 Female Infertility Market: End-use Movement Analysis 2022 & 2030 (USD Million)
- 6.2 Fertility Clinics
- 6.2.1 Fertility clinics market estimates and forecasts, 2018 - 2030 (USD Million)
- 6.3 Hospitals
- 6.3.1 Hospitals market estimates and forecasts, 2018 - 2030 (USD Million)
Chapter 7. Female Infertility Market: Regional Estimates & Trend Analysis, By Therapeutic Areas and End-use
- 7.1 Regional Market Snapshot
- 7.2 Female Infertility Market Share, By Region, 2022 & 2030 (USD Million)
- 7.3 Market Share Analysis, by Country, 2022
- 7.4 SWOT Analysis, by Factor (Political, Legal, Economic and Technological)
- 7.4.1 North America
- 7.4.2 Europe
- 7.4.3 Asia Pacific
- 7.4.4 Latin America
- 7.4.5 MEA
- 7.5 North America
- 7.5.1 North America female infertility market estimates and forecasts, 2018 - 2030 (USD Million)
- 7.5.2 U.S.
- 7.5.2.1 The U.S. female infertility market estimates and forecasts, 2018 - 2030 (USD Million)
- 7.5.3 Canada
- 7.5.3.1 Canada female infertility market estimates and forecasts, 2018 - 2030 (USD Million)
- 7.6 Europe
- 7.6.1 Europe female infertility market estimates and forecasts, 2018 - 2030 (USD Million)
- 7.6.2 UK
- 7.6.2.1 UK female infertility market estimates and forecasts, 2018 - 2030 (USD Million)
- 7.6.3 Germany
- 7.6.3.1 Germany female infertility market estimates and forecasts, 2018 - 2030 (USD Million)
- 7.6.4 Spain
- 7.6.4.1 Spain female infertility market estimates and forecasts, 2018 - 2030 (USD Million)
- 7.6.5 France
- 7.6.5.1 France female infertility market estimates and forecasts, 2018 - 2030 (USD Million)
- 7.6.6 Italy
- 7.6.6.1 Italy female infertility market estimates and forecasts, 2018 - 2030 (USD Million)
- 7.6.7 Denmark
- 7.6.7.1 Denmark female infertility market estimates and forecasts, 2018 - 2030 (USD Million)
- 7.6.8 Sweden
- 7.6.8.1 Sweden female infertility market estimates and forecasts, 2018 - 2030 (USD Million)
- 7.6.9 Norway
- 7.6.7.1 Norway female infertility market estimates and forecasts, 2018 - 2030 (USD Million)
- 7.7 Asia Pacific
- 7.7.1 Asia Pacific female infertility market estimates and forecasts, 2018 - 2030 (USD Million)
- 7.7.2 Japan
- 7.7.2.1 Japan female infertility market estimates and forecasts, 2018 - 2030 (USD Million)
- 7.7.3 China
- 7.7.3.1 China female infertility market estimates and forecasts, 2018 - 2030 (USD Million)
- 7.7.4 India
- 7.7.4.1 India female infertility market estimates and forecasts, 2018 - 2030 (USD Million)
- 7.7.5 South Korea
- 7.7.5.1 South Korea female infertility market estimates and forecasts, 2018 - 2030 (USD Million)
- 7.7.6 Thailand
- 7.7.6.1 Thailand female infertility market estimates and forecasts, 2018 - 2030 (USD Million)
- 7.7.7 Australia
- 7.7.7.1 Australia female infertility market estimates and forecasts, 2018 - 2030 (USD Million)
- 7.8 Latin America
- 7.8.1 Latin America female infertility market estimates and forecasts, 2018 - 2030 (USD Million)
- 7.8.2 Brazil
- 7.8.2.1 Brazil female infertility market estimates and forecasts, 2018 - 2030 (USD Million)
- 7.8.3 Mexico
- 7.8.3.1 Mexico female infertility market estimates and forecasts, 2018 - 2030 (USD Million)
- 7.8.4 Argentina
- 7.8.4.1 Argentina female infertility market estimates and forecasts, 2018 - 2030 (USD Million)
- 7.9 MEA
- 7.9.1 MEA female infertility market estimates and forecast, 2018 - 2030 (USD Million)
- 7.9.2 Saudi Arabia
- 7.9.2.1 Saudi Arabia female infertility market estimates and forecasts, 2018 - 2030 (USD Million)
- 7.9.3 UAE
- 7.9.3.1 UAE female infertility market estimates and forecasts, 2018 - 2030 (USD Million)
- 7.9.4 South Africa
- 7.9.4.1 South Africa female infertility market estimates and forecasts, 2018 - 2030 (USD Million)
- 7.9.5 Kuwait
- 7.9.5.1 Kuwait female infertility market estimates and forecasts, 2018 - 2030 (USD Million)
Chapter 8 Company Profiles
- 8.1 Ferring B.V.
- 8.1.1 Company overview
- 8.1.2 Financial performance
- 8.1.3 Product benchmarking
- 8.1.4 Strategic initiatives
- 8.2 Vitrolife AB
- 8.2.1 Company overview
- 8.2.2 Financial performance
- 8.2.3 Product benchmarking
- 8.2.4 Strategic initiatives
- 8.3 CooperSurgical, Inc.
- 8.3.1 Company overview
- 8.3.2 Financial performance
- 8.3.3 Product benchmarking
- 8.3.4 Strategic initiatives
- 8.4 Cosmos Biomedical Ltd.
- 8.4.1 Company overview
- 8.4.2 Financial performance
- 8.4.3 Product benchmarking
- 8.4.4 Strategic initiatives
- 8.5 Merck KGaA
- 8.5.1 Company overview
- 8.5.2 Financial performance
- 8.5.3 Product benchmarking
- 8.5.4 Strategic initiatives
- 8.6 Cryolab Ltd.
- 8.6.1 Company overview
- 8.6.2 Financial performance
- 8.6.3 Product benchmarking
- 8.6.4 Strategic initiatives
- 8.7 FUJIFILM Irvine Scientific
- 8.7.1 Company overview
- 8.7.2 Financial performance
- 8.7.3 Product benchmarking
- 8.7.4 Strategic initiatives
- 8.8 Bloom IVF Centre
- 8.8.1 Company overview
- 8.8.2 Financial performance
- 8.8.3 Product benchmarking
- 8.9 Microm UK Ltd.
- 8.9.1 Company overview
- 8.9.2 Financial performance
- 8.9.3 Product benchmarking
- 8.10 OvaScience
- 8.10.1 Company overview
- 8.10.2 Financial performance
- 8.10.3 Product benchmarking
- 8.10.4 Strategic initiatives
- 8.11 Irvine Scientific
- 8.11.1 Company overview
- 8.11.2 Financial performance
- 8.11.3 Product benchmarking
- 8.11.4 Strategic initiatives
- 8.12 Progyny, Inc.
- 8.12.1 Company overview
- 8.12.2 Financial performance
- 8.12.3 Product benchmarking
- 8.12.4 Strategic initiatives
- 8.13 EMD Serono Inc.
- 8.13.1 Company overview
- 8.13.2 Financial performance
- 8.13.3 Product benchmarking
- 8.13.4 Strategic initiatives
- 8.14 Thermo Fisher Scientific Inc.
- 8.14.1 Company overview
- 8.14.2 Financial performance
- 8.14.3 Product benchmarking
- 8.14.4 Strategic initiatives
- 8.15 Boston IVF
- 8.15.1 Company overview
- 8.15.2 Financial performance
- 8.15.3 Product benchmarking
- 8.15.4 Strategic initiatives
GET A FREE SAMPLE
This FREE sample includes market data points, ranging from trend analyses to market estimates & forecasts. See for yourself.
NEED A CUSTOM REPORT?
We can customize every report - free of charge - including purchasing stand-alone sections or country-level reports, as well as offer affordable discounts for start-ups & universities.
Contact us now to get our best pricing.
ESOMAR certified & member
ISO Certified
We are GDPR and CCPA compliant! Your transaction & personal information is safe and secure. For more details, please read our privacy policy.